







Final dissertation report 
Oral bioavailability of Polycyclic Aromatic Hydrocarbons in 
atmospheric particulate matter 
Biodisponibilidad oral de Hidrocarburos Aromáticos Policíclicos 
en material particulado atmosférico 
Biodispoñibilidade oral de Hidrocarburos Aromáticos 




Advisors:  Jorge Moreda Piñeiro 
                         Purificación López Mahía 
 
Paula Gómez Meijide 















                    UNIVERSIDADE DA CORUÑA 
 
Dr. Jorge Moreda Piñeiro, and Dr. Purificación López Mahía, Associate Professors at the 
Department of Chemistry (Analytical Chemistry Section) of the Faculty of Science of the University of 
A Coruña, 
CERTIFY: 
That the work described in the present report, titled “Oral bioavailability of PAHs in 
particulate matter” was carried out under their guidance by Ms. Paula Gómez Meijide in the Faculty 
of Science laboratories and, once concluded, authorize its presentation as a Final Degree Dissertation 
Report. 
And, for the record, sign the present certificate at A Coruña on         
 
 





Facultade de Ciencias 





First of all, to the Applied Analytical Chemistry Department for allowing me to develop this 
study with them, specially to my  advisors, Jorge and Puri, for teaching me with patience, giving me 
always support and, most important, confidence. 
To Joel, for being there day after day available at any time for anything I needed, for teaching 
me things every day and for making the laboratory work much more pleasant. I am going to miss all 
the good times, that were not few, and of course complaining together when an equipment did not 
work. 
To Vero, Carmen and Fany, for making me feel at home from the first day and making coffee 
time, the most expected moment in the morning, because for me, you are the pillar of this 
laboratory. For shearing every day a little bit of your life and making me laugh, because I have learnt 
that everything in this life has its “chupi” part.  In particular, express my gratitude to Fany for the 
morning conversations and also for all the things you have done for me during these months. 
To all the people with whom I have coincided in the lab, particularly to the teachers, because 
despite being a student, they have been treated me as a colleague. 
To my “Cenas Química”, you are the best of these years, because of the millions of sheared 
moments, the lost hours in the cafeteria, all the nights giving war, and without doubt, thank you 
Grobas for all your notes, none of this would have been possible without you. Because despite being 
such different people, I can say that I have made great friends these years. 
To my friends and workmates for supporting me. 
And finally, to my family, my parents, my grandparents and Miguel, for having always been 
there, because you taught me to fight in difficult moments and also that everything is possible with 















- Ace: acenaphthene. 
- Ant: anthracene. 
- BaA: benzo(a)anthracene. 
- BaP: benzo(a)pyrene. 
- BbF: benzo(b+j)fluoranthene. 
- BC: Black Carbon. 
- BeP: benzo(e)pyrene. 
- BghiP: benzo(ghi)perylene. 
- BkF: benzo(k)fluoranthene 
- COV: Organic Volatile Compounds. 
- Chry: chrysene 
- DBahA: dibenzo(a,h)anthracene. 
- EC: Elementary Carbon. 
- Fl: fluorene. 
- Ft: fluoranthene. 
- GC: Gas Chromatograph. 
- HAPs: Hidrocarburos Aromáticos Policíclicos. 
- HPLC: High Performance Liquid Chromatography. 
- HPLC-FD: High Performance Liquid Chromatography coupled with Fluorescence 
Detection. 
- IP: indene(1,2,3-cd)pyrene. 
- LOD: Limit of Detection. 
- LOQ: Limit of Quantification. 
- MASE: Membrane-Assisted Solvent Extraction. 
- MWCO: Molecular Weight Cut-off. 
- Naph: naphthalene. 
- OC: Organic Carbon. 
- PAHs: Polycyclic Aromatic Hydrocarbons. 
- Phe: phenanthrene. 
- PHWE: Pressurized Hot Water Extraction. 
- PIPES: 1,4-Piperazinediethanesulfonic acid sodium salt. 
- PM: Particulate Matter. 
- PP: polypropylene. 
- PTV-GC-MS/MS: Programmed Temperature Vaporization-Gas Chromatography-Ion Trap 
tandem Mass spectrometry detection. 
- Pyr: pyrene. 
- SWE: Subcritical Water Extraction. 
- TSP: Total Suspended Particulate. 
- USEPA: United States Environmental Protection Agency. 
- VALLME: Vortex Asissted Liquid-Liquid Microextraction. 
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The transport of deposited particles in lung during breathing to the gastrointestinal tract is one 
of the clearance mechanism that may occur into the respiratory system. In the context of human health-
risk assessment, oral bioavailability refers to the pollutant fraction that diffuses across the 
gastrointestinal tract and reach the systemic circulation (blood).   
The main aim of this research is the development of a novel in-vitro testing to assess the oral 
bioavailability of polycyclic aromatic hydrocarbons (PAHs) in PM10 samples at urban site of A Coruña, 
and the accurately toxicity prediction of PAHs in PM10 using bioavailable concentrations. In-vitro oral 
bioavailability test involves the use of pepsin solution for simulated gastric digestion (37 ºC, 150 rpm, 
120 min) and pancreatin/bile salts solution for simulated intestinal digestion (37 ºC, 150 rpm, 120 min). 
During simulated intestinal digestion, a dialysis membrane of 10 kDa MWCO filled PIPES (1,4-
Piperazinediethanesulfonic acid sodium salt) solution (pH 7.5) was used to simulate cell walls of the 
intestine.  
Total PAHs concentrations of the samples were necessary to determine in order to obtain 
bioavailable percentages, by using an already developed new green analytical method. Low oral 
bioavailability ratios (< 1 %) were found for several PAHs such fluoranthene, pyrene, 
benzo(a)anthracene, chrysene, benzo(e)pyrene and benzo(k)fluoranthene. 
 




El transporte de las partículas depositadas en los pulmones durante la respiración al tracto 
intestinal es uno de los mecanismos de despeje que tienen lugar en el sistema respiratorio. En el 
contexto humano de la evaluación del riesgo de la salud, la biodisponibilidad oral hace referencia a la 
fracción de contaminante que se difunde a través del tracto gastrointestinal y llega al sistema 
circulatorio. 
El principal objetivo de esta investigación es el desarrollo de un nuevo método in-vitro para 
evaluar la biodisponibilidad oral de hidrocarburos aromáticos policíclicos (HAPs) en muestras de PM10 
procedentes de una zona urbana de la ciudad de A Coruña, y de la predicción apropiada de la toxicidad 
de los HAPs en PM10 utilizando las concentraciones biodisponibles. El estudio de biodisponibilidad oral 
in-vitro implica el uso de pepsina para realizar la simulación gástrica (37 °C, 150 rpm, 120 min) y de 
pancreatina y sales biliares para la simulación de la digestión intestinal (37 °C, 150 rpm, 120 min). 
Durante la simulación de la digestión intestinal, una membrana de diálisis de 10kDa MWCO que 
contiene una disolución de PIPES (1,4-Piperazinediethanesulfonic acid sodium salt) a pH 7,53 se emplea 
para simular las paredes celulares del intestino. 
Las concentraciones totales de HAPs de las muestras se determinaron para obtener los 
porcentajes de biodisponibilidad utilizando un método de análisis verde ya desarrollado. Se obtuvieron 
bajos porcentajes de biodisponibilidad (< 1 %)  para algunos HAPs, como para el fluoranteno, pireno, 
benzo(a)antraceno, criseno, benzo(e)pireno y benzo(k)fluoranteno. 
 





O transporte das partículas depositadas nos pulmóns durante a respiración ó tracto intestinal é 
uno dos mecanismos de despexe que teñen lugar no sistema respiratorio. No contexto humano da 
evaluación do risco da saúde, a biodispoñibilidad oral fai referencia á fracción de contaminante que se 
difunde a través do tracto gastrointestinal e chega ó sistema circulatorio. 
O principal obxectivo desta investigación é  o  desarrollo dun novo método in-vitro para a  
avaliación  da biodispoñibilidade oral de hidrocarburos aromáticos policíclicos (HAPs) en mostras de 
PM10 procedentes dunha zona urbana da ciudad de A Coruña, e da predicción apropiada da toxicidad 
dos HAPs en PM10  utilizando as concentracións biodispoñibles. O estudio de biodispoñibilidade oral in-
vitro implica o uso de pepsina para realizar a simulación gástrica (37 °C, 150 rpm, 120 min) e de 
pancreatina e sales biliares para a simulación da dixestión intestinal (37 °C, 150 rpm, 120 min). Durante 
a simulación da dixestión intestinal, unha membrana de diálise de 10kDa MWCO que contén unha 
disolución de PIPES (1,4-Piperazinediethanesulfonic acid sodium salt) a pH 7,53  empléase para simular 
as paredes celulares do intestino. 
As concentracións totales de HAPs das mostras foron determinadas para obter as porcentaxes 
de biodispoñibilidade utilizando un método de análise verde xa desarrollado. Baixas porcentaxes de 
biodispoñibilidade (< 1 %) foron obtidas para alguns HAPs, como para o fluoranteno, pireno, 
benzo(a)antraceno, criseno, benzo(e)pireno e benzo(k)fluoranteno. 
 









2.1 Particulate matter. 
Particulate Matter (PM) is the combination of solid and liquid materials (excluding pure water) 
suspended in the atmosphere that has different nature, composition, properties, effects, number, shape 
and size, which can fluctuate between 0.001 – 100 μm3. It is considered a complex system in continuous 
evolution due to the big amount of chemical species that constitute the particulate matter (López-
Mahía, 2016). 
PM can be classified independently according to their mechanism of formation, their emission 
sources and their size. The suspended particles can be primary or secondary pollutants. If they are 
directly emitted to the atmosphere and maintain their initial chemical structure, they are called primary. 
On the other hand, secondary particles are originated in the atmosphere as a result of chemical 
reactions with other substances called gas precursors. The most important gas precursors presented in 
the atmosphere are SO2, NOx and Organic Volatile Compounds (COV).  
 According to their emission sources, it is possible to differentiate the naturals and the 
anthropogenic ones. In natural sources it should be pointed out the mineral fraction originated by the 
natural floor emissions, a part from the volcanic ones, and the particles generated from the sea´s 
surface, called marine aerosol. Nevertheless, the anthropogenic sources catch the attention and interest 
because they are the ones which occur close to the population, in fact, they are generated in urban and 
industrial areas. Traffic emissions constitute the main source of primary particles, although it is 
important to consider the wide variety of industrial activities, specially the combustion of coal and 
another ones such as the foundry of metals like copper or zinc, the production of cement and pottery. 
Furthermore, there are domestic actions which contribute with the anthropogenic emissions 
(MeteoGalicia y Laboratorio de Medio Ambiente de Galicia, 2017). 
As it was mentioned before, particulate matter encompasses an extensive range of sizes arising 
from their diameter, including: coarse particles or PM2.5 – 10 (with a diameter between 2.5 – 10 μm), fine 
particles or PM2.5 (with a diameter less than or equal to 2.5 μm), ultrafine particles or PM0.1 (with a 
diameter less than or equal to the 0.1 μm) and nanoparticles or PM0.05 (with a diameter less than or 
equal to 0.05 μm) (Hester et al., 2016). 
In addition, it is important to consider that the composition of the particulate matter is a wide 
ranging, being the mineral matter and the marine spray the ones with a highest influence. But it is also 




 Mineral matter: 
 They are mainly primary particles that come from the wind action over the land surface, being 
predominant in arid areas. Their chemical composition fluctuate depending on their section, and 
mainly exhibit quartz, calcium and magnesium carbonates, feldspars, aluminosilicates, sulphates, 
phosphates and metallic oxides. This group provides the majority fraction in terms of mass of 
particulate matter. 
 Marine sprays:  
They are primary natural particles derived from oceans and seas, which are composed of marine 
salt (NaCl), apart from sodium and magnesium chlorides and sulphurs. It is the group with the second 
greatest influence in terms of emissions. 
 Compounds derived from sulphur:  
Their principal component is sulphur and they have a biogenic origin, but also an anthropogenic 
one, coming from the fuels burning. Inorganic compounds are included, and organic ones of secondary 
origins are included too. 
 Compounds derived from nitrogen: 
 They are the ones whose main component is nitrogen, and their main emission sources are, on 
the one hand naturals, such as the land, biomass combustion and microorganism´s emissions, and on 
the other hand, anthropogenics, like farming and stockbreeding. 
 Carbon compounds:  
The group includes the elementary carbon (EC), also named as black carbon (BC) and the organic 
carbon (OC). The black carbon is directly emitted to the atmosphere from the incomplete combustion 
of coal, gas or biomass, whereas the organic carbon can be primary or being formed different 
precursors (López-Mahía, 2016). 
 
2.2 Legislation. 
Until 1972, there was no environmental regulation related to the atmospheric particles. It was 
then when appeared the first one, the Law 38/1972 (December, 1972) of Protection of the atmospheric 
ambient which considered the Total Suspended Particulate (TSP) as a quality air parameter (García-
Gaico, 2013). However, the current legislation about quality and evaluation of the air was born with de 
Directive 96/62/CE, knowing as the Mother Directive, which adopted a general approach and fixed some 
criterions, objectives and evaluation techniques. 
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In the following years, the Mother Directive was supplemented with four extra directives, 
named the Daughter Directives, developing different regulation for different air pollutants (Marco Legal 
de la Calidad del Aire,  2019): 
- The Directive 1999/30/CE or 1st Daughter Directive (April, 1999) related to limit values of 
SO2, NO2, NO and lead air particles. 
- The Directive 2000/69/CE or 2nd Daughter Directive (November, 2000) related to the limit 
values of benzene and CO in the air. 
- The Directive 2002/3/CE or 3rd Daughter Directive (February, 2002) related to the ozone in 
the air. 
- The Directive 2004/107/CE or 4th Daughter Directive (December, 2004) related to arsenic, 
cadmium, mercury, nickel and aromatic polycyclic hydrocarbons in the air. 
Nowadays, the European regulation of air quality comes from the following Directives 
(Normativa europea, 2019)  
- The Directive 2004/107/CE of the European Parliament and the Council (December, 2004) 
also knowing as the 4th Daughter Directive, is the only one of the Original Frame that is still 
in effect. 
- The Directive 2008/50/CE of the European Parliament and the Council (May, 2008) related 
to the environmental air quality and an European clean atmosphere, which was approved 
with the aim of reducing the atmospheric pollution and maintaining a good air quality. It 
also added regulation for new pollutants such as the PM2.5 and some rules and guidelines 
from the World Health Organization (WHO). 
- The Decision 2011/850/UE (December, 2015) addressed the information interchange and 
notification of the air quality in all the countries of the European Union. 
- The Directive 2015/148/CE (August, 2015) modified some appendix of 2004/107/CE and 
2008/50/CE Directives, where were established particular reference methods, data 
validations and the location of certain measuring stations. 
- The Directive 2016/2284/UE of the European Parliament and the Council (December, 2016) 
related to the reduction of national emissions of certain atmospheric pollutants, forcing to 
all the components of the European Union not to exceed annually in 2020 some fixed values 
of sulphur dioxide, nitrogen oxides, organic volatile compounds and ammonia. 




- The Law 34/2007 (November, 2007) of the air quality and protection of the atmosphere, 
that update the legal bases for developments related to the evaluation and management of 
the air quality in Spain, and whose main aim is to achieve optimal levels of air quality in 
order to avoid, prevent and reduce the risks and negative effects on the human´s health and 
the environment. 
- The Royal Decree Law 102/2011 (January, 2011) related to the improvement of the air 
quality, fixing limit values for different air pollutants. 
 
Figure 1. Legislation diagram. 
Previously to the evaluation of the air quality, the territory of Spain is divided into some areas 
based on homogeneity criteria of emission and concentration of pollutants. In each area is carried out 
the evaluation and management of the air quality by using some measuring stations. In these places are 
controlled the fixed parameters in the Royal Decree Law 102/2011, with  limit and target values (Tables 
1 and 2) (Ministerio de Agricultura, Pesca y Alimentación, 2017). 
 
Pollutant 







SO2 1 hour 350 μg/m
3     < 24 hours/year 2005 
24 hours  125 μg/m3       < 3 days/year 
NO2 1 hour  200 μg/m
3     < 15 hours/year 2010 
1 year  40 μg/m3  
PM10 24 hours  50 μg/m
3      < 35 days/year 2005 
1 year  40 μg/m3  
PM2.5 1 year 25 μg/m
3  2015 
Pb 1 year 25 μg/m3  2015 
C6H6 1 year 5 μg/m
3  2010 
 












O3 Daily maximum of 8hours 
mobile average 
120 μg/m3 < 25 days/year ( in an 
average of 3 years) 
2010 
As 1 year 6 ng/m3  2013 
Cd 1 year 5 ng/m3  2013 
Ni 1 year 20 ng/m3  2013 
B(a)p 1 year 1 ng/m3  2013 
 
Table 2. Target values of some pollutants. 
2.3 Health effects associated to particulate matter. 
In the last decade, hundreds of scientific publications associated to the particulate matter 
exposure have been published, providing toxicological and epidemiological effects. Although the 
particulate matter affects to the whole population, the groups that have developed a high sensitive are 
the elderly ones besides the unborn babies and very young children (World Health Organization, 2010). 
The particulate matter exposure is considered the reason of the increment of hospital 
admissions, emergency room visits, respiratory symptoms, exacerbation of respiratory and 
cardiovascular diseases, premature mortality and a decrease lung function. 
As a result of these studies, it is assessed than at least 3% of cardiopulmonary and 5% of lung 
cancer deaths are related with particulate matter. Moreover, it is possible to relate that the increment 
of μg/m3 in PM10 levels produces the increment of the number of deaths in a 0.6% (Kim, Kabir and Kabir, 
2015). 
 
2.4 Risk assessment: bioaccesibility and bioavailability. 
The potential health risk of some pollutants that is present in particulate matter arises from the 
inhalation of these particles during breathing, followed by the deposition and diffusion of the particles 
into the respiratory tract. In order to improve risk assessment, the concentrations of the pollutants have 
to be considered, but it is also important to consider how they are assimilated by the people exposed 
(Mukhtar and Limbeck, 2013). 
Despite the fact that the effect of particulate matter exposure is related with the physical 
characteristics of each person, the particle´s size is directly proportional to their potential of causing 
health problems owing to they can penetrate into the human´s body. The particles with a highest impact 
on human health effects are those with less than 10 μm of diameter, and, the smaller is the particle, 













Figure 2. Diagram of the penetration of the particulate matter according to their size. 
The followed pathway of the particulate matter (Figure 2) goes from the nasal passages until the 
alveoli, being able to reach the depth of the lungs because of their huge penetrability. First of all, when 
the air is introduced into the nose or the mouth and goes to the throat, it is directly filtered because the 
body reacts in order to eliminate these strange particles using process like sneezes and cough (López-
Mahía, 2016). 
Once the particles are inside the extrathoracic or nasopharyngeal region, there is an equilibrium 
among them and the body temperature and humidity, being the large particles restricted (Kastury, 
Smith and Juhasz, 2017). After that, they penetrate into the respiratory tract, remaining retained the 
particles between 5 and 10 μm in the tracheobronchial tree, while those between 1 and 5 μm can be 
stretched until bronchioles and alveolis. These are the specifical ones which can affect to the gaseous 
interchange that takes place into the lungs, being able to penetrate inside and get to the bloodstream 
(López-Mahía, 2016). 
Nowadays, published researches study toxicity taking into account the bioaccessibility and 
bioavailability terms. Considering these two expressions, once the particles are deposited into the 
respiratory tract, the clearance of them can take place by one of these three mechanisms: absorption of 
the dissolved fraction by blood (inhalation bioaccessibility/bioavailability), transport to the 
gastrointestinal tract (oral bioaccessibility/bioavailability) and transport to the lymph node. Depending 
on the mechanism that the particles follow, it is possible to distinguish between oral and inhalation 
bioaccessibility and bioavailability (Kastury, Smith and Juhasz, 2017). 
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 Inhalation bioaccesibility is defined as the fraction of toxicants dissolved in simulated 
tracheobronchial fluids that is potentially available to cross the air-blood barrier and to reach blood 
circulation, whereas inhalation bioavailability is the concentration of pollutants that cross the air-blood 
barrier and reach the blood circulation. 
The first step to oral bioavailability assessment is the study of oral bioaccessibility, which is 
associated with the pollutant fraction soluble in the gastrointestinal tract that is available for absorption 
(Ruby et al., 1999). Thereby oral bioavailability can be defined, being related to the pollutant fraction 
which goes through the gastrointestinal tract and reaches blood circulation. 
Notwithstanding the evaluation of human data provides the most relevant information about 
particulate matter toxicity, human exposure studies can be easily variable. That is why nowadays, the 
bioaccessibility and bioavailability studies are done using different exposure methods: 
 In-vivo experiments: 
Bioaccessibility and bioavailability can be evaluated by in-vivo models using animals such as rats, 
hamsters and swines. They are supposed to be anatomically, physiologically and metabolically similar to 
humans. Nevertheless, they are expensive and time-consuming experiments, and there are some ethical 
implications that try to avoid harmful effects. Furthermore,  the obtained data is limited and there is 
inaccuracy when it is extrapolated to humans (Turner, 2011). 
 In-vitro exposure to cultured cells: 
Animal or human cell lines are exposed to pollutant solutions in order to measure the 
bioaccessible/bioavailable fraction. Its main advantage over in-vivo experiments are the ease of 
operation and the fewer bureaucratic requirements regarding ethic committees. Frequently, these kinds 
of experiments are performed using lung ephitelial and alveolar monocultures due to it is where the 
particulate matter deposition occurs. However, there are more than forty types of cells in the 
respiratory system, therefore, it is not a representative approach (Kastury, Smith and Juhasz, 2017). 
Considering oral bioavailability, cell studies have been developed in conjunction with in-vitro digestion 
techniques where gastric and intestinal digestion are simulated using commercially available digestive 
enzymes, being the final absorption process assessed using Caco-2 cell lines (Glahn et al., 1998). Caco-2 
cells are a human intestinal cell model that comes from a colon carcinoma which experiments a 
spontaneous differentiation in culture and display similar characteristics to enterocytes. Despite of their 
colonic origin, Caco-2 cells show the same morphology and functionality as small intestinal cells (Braga 




 In-vitro experiments: 
It is the best approximation to the evaluation of the particulate matter toxicity. Synthetic 
gastrointestinal and pulmonary fluids are used and human´s body conditions like pH, temperature, 
agitation and chemical composition are simulated to estimate the concentration of target compounds. 
They are cheaper experiments with a greater ease of control, have a good reproducibility and high 
precision and accuracy, being able to be validated using reference materials (Moreda-Piñeiro, Moreda-
Piñeiro and Bermejo-Barrera, 2017). 
 
2.5 Background. 
The terms bioavailability and bioaccessibility were born in England. In the 80´s, food 
contamination established an important concern due to the bad soil conditions. For this reason, metals 
were the first analytes that were studied in these kinds of investigations. In 1981, the oral bioavailability 
of iron from meals was determined (Miller et al., 1981), providing an essential contribution to the 
calculation of the bioavailable fraction using in-vitro methods. 
After that, another oral metal bioavailabilities were analyzed, such as the determination of iron 
in food (Luten et al., 1996), lead in forest soil (Turpeinen, Salminen and Kairesalo, 2000) and cadmium in 
sediments (DeWitt et al., 2005).  
Bioaccessibility has been also determined in a lot of researches, having better progresses. For 
instance, the application area has been quickly increased, being included apart from metals in food and 
soils, many organic compounds and other sample matrix  that constitute a significant health risk. It was 
applied to the oral bioaccessible fraction quantification of metals in dusts (Turner, 2011), phthalate 
esters in indoor/outdoor dusts (Wang, Wu, et al., 2013) and chlorinated organophosphate flame 
retardants in indoor dust (Quintana et al., 2017) besides many others.  Moreover, the inhalation 
bioaccessible fraction has been also studied, for example in polychlorinated biphenyls (PCBs) contained 
in indoor and outdoor dusts (Wang, Huang, et al., 2013) and in trace metals in particulate matter 
(Mukhtar and Limbeck, 2013). 
There are also comparative experiments, like the in-vivo/in-vitro assessment of  oral 
bioaccessibility and bioavailability of arsenic, selenium and mercury species in food samples (Moreda-
Piñeiro et al., 2011) and limitations of inhalation bioaccessibility and bioavailability reviews of metals in 
particulate matter and dusts (Kastury, Smith and Juhasz, 2017). 
Nonetheless, it is possible to see that there are a lot of studies based on the bioaccessibility of 
different analytes in different fields, but it is not very easy to find this diversity when discussing about 
bioavailability. Until a few years ago, the bioavailability studies focused their interest on metals; 
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however, in recent years they have been extended to some organic compounds such as polycyclic 
aromatic hydrocarbons, which is our analyte of interest. 
 
2.6 Polycyclic Aromatic Hydrocarbons. 
Polycyclic Aromatic Hydrocarbons (PAHs) are an ubiquitous group of organic compounds  
composed only of carbon and oxygen which form, at least, two fused aromatic benzene rings and 
additional ones with less than six carbons (Figure 3) (Callén et al., 2013).  They are characterized by 
being lipophilic, having high melting and boiling points, low vapour pressure and low water solubility 
(Jackson, 2017). 
PAHs can be distinguished depending on their molecular weight: if they have less than three fused 
rings are named as low molecular weight and appear normally in the vapour phase of the atmosphere, 
whereas if they have more than four, are high molecular weight PAHs which are largely bound to 
particles. The ones with four fused rings are distributed between the particulate and the atmosphere 
phases depending on the atmosphere temperature. Those particles bounded to PAHs are very 
hazardous to human´s health (World Health Organization, 2010). 
They are a widespread group of pollutants that come from the incomplete combustion of organic 
materials which are originated by two different sources, naturals and anthropogenics. Volcanic 
eruptions and forest fires are the main natural sources of PAHs; however, the most important ones are 
anthropogenics. The main anthropogenic fraction comes from the partial combustion of coal, diesel, 
wood, vegetation and the elimination of fumes from manufacturing industries. In addition, there are 
daily life sources like the environmental tobacco smoked and the wood-stove (Yebra-Pimentel et al., 
2015). The sources of these pollutants vary based on if we are analyzing outdoor air, where traffic 
emissions have a greatest contribution; or indoor air, where tobacco, cooking and heating have a bigger 
impact on the total concentration (World Health Organization, 2010). 
Due to these characteristics, many organizations such as the United States Environmental 
Protection Agency (USEPA) have listed 16 PAHs (Figure 3), being some of them considered probable 
human carcinogens and mutagenics as priority pollutants, in particular, the benzo(a)pyrene (BaP), that 
has been used as a marker of all the PAHs for many years because it is the most powerful one, and also 
the most regulated. The benzo(a)anthracene, chrysene and dibenzo(a,h)anthracene have to be taken 




 Figure 3: Structure of the 16 PAHs listed by the USEPA  
 
2.7 Bioaccessibility and bioavailability of polycyclic aromatic hydrocarbons. 
Since bioacessibility and bioavailability appeared as new concepts, they are current issues in 
environmental chemistry, and are the focus of many analytical researches. The studies of PAHs started 
being in soils, and, over the years, it was spread out to food issues. Nowadays, the first studies related to 
particulate matter have just been appeared, and are the contemporary centre of interest. Some actual 
examples are shown below. 
The oral bioaccessibility of polycyclic aromatic hydrocarbons has been estimated in seafood, 
which varies depending on the foodstuff and the cooked:  it was obtained a 59.29% in dried seaweed, a 
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84,2 % of phenanthrene in steamed clams, and a 22,0 % of benzo(k)fluoranthene in raw clams, whereas 
in steamed clams, the bioaccessible fraction is the 55,5 % (Helena et al., 2018). 
There are also  soil samples studies, for example in different areas of in Nigeria, were the 
bioaccessibility percentages of one of them are shown in Table 3 (Adetunde et al., 2018). 






Table 3. Oral bioaccesible fraction of PAHs in Nigerian soil. 
In addition, there are some studies about inhalation bioaccessibility in PM2.5, where the 
bioaccessibility of PAHs range from 3,21 % in the benzo(c)fluoranthene to  44,2 % in acenaphthylene (Li 
et al., 2019). 
Despite these examples, the number of studies related to oral bioaccesibility and bioavailability 









The particulate matter is formed by different compounds, being many of them hazardous to 
human´s health. There is regulation related to the atmospheric concentration of some compounds in 
order to protect environmental conditions, but it is not enough. For this reason, it is necessary to extend 
the risk assessment not only to the determination of total concentration of pollutants, but also to the 
bioaccessible and bioavailable fractions.  
This final dissertation report is focused on the achievement on the total concentration and the 
bioavailable fraction of polycyclic aromatic hydrocarbons by using an in vitro approach of particulate 
matter with a diameter equal or less than 10 μm.  The aim is to calculate the relation between the 
bioavailable and the total concentration of these compounds owing to know what amount of the total 















4. Experimental procedure. 
4.1 Instruments and equipments. 
- Electronic analytical balance ADN, EA-180A model, with an accuracy of ±0.0001 g (Thebarton 
SA, Australia). 
- GRAM balance, SV-510ix model, with an accuracy of 0.001 g (Barcelona, Spain). 
- PHmeter, CRISON microPH 2001. 
- Centrifuge, Eppendorf 5804 (Hamburg, Germany). 
- Accelerated Solvent Extractor Dionex ASE 200 system (Sunnyvale CA, USA), equipped with 
stainless-steel extraction cells of 11 cm and cellulose filters (D18, 1.983 cm of diameter) also 
from Dionex. 
- Incubator, Boxcult incubator and agitator Rotabit orbital-rocking platform shaker (J.P. 
Selecta, Barcelona, Spain). 
- High-volume sampler, Digitel DH-80 (Digitel Electronik AG, Hegnau, Switzerland). 
- PM10 size selective inlet, Graseby-Andersen Gibsonville (TISCH Environmental INC Cleves, 
Ohio, EEUU). 
- Vortex, IKA-VIBRAX-VXR Drogallega (Galicia, Spain). 
- High Performance Liquid Chromatography (HPLC) system, Waters 2695 Alliance with 
automatic injection, which is directly connected to two detectors, a photodiode array 
detector (Waters, 996) and fluorescence detector (Waters 2475, multi λ fluorescence 
detector) (Milford, MA, USA). 
- Gas Chromatography (GC), Thermo-Finnigan (Waltham, MA, USA) Trace GC chromatograph 
equipped with a GC PAL autosampler (CTC-Analytics, Zwingen, Switzerland), Programmed 
Temperature Vaporizing (PTV) injector and coupled to an ion trap mass spectrometer (Polaris 
Q).  
- Automatic micropipettes, Eppendorf  Research, of variable volumes: 500-5000, 100-1000, 20-
200, 10-100 and 2-20 μL. 
4.2 Consumable material. 
- Volumetric glass material, class A. 
- 100 mL umber glass flask. 
- Tweezers. 
- Steel punching tool (Selecta, Barcelona, Spain). 
- Disposable glass pipettes. 
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- Dialysis membranes, Cellu Sep® H1 high grade regenerated cellulose tubular membranes 
(molecular weight cutoff 10 kDa, 50 cm x 25.5 mm), Membrane Filtration Products Inc 
(Seguin, TX, EEUU). 
- Quartz fiber filteres, PM10 QF20 quartz fiber filters 27 cm×15 cm, (Schleicher&Schuell, D-
Dassel, Germany). 
 
4.3 Chemical reagents. 
- Milli-Q water with a 18 MΩcm-1 resistivity and obtained by using Milli-Q purification system, 
Millipore Co (Bedford, MA, USA). 
- PAH calibration mix  of certified reference material, 10 μg/mL each component  in acetonitrile, 
containing naphthalene, acenaphthylene, acenaphthene, fluorene, phenanthrene, anthracene, 
fluoranthene, pyrene, benzo(a)anthracene, chrysene, benzo(b)fluoranthene, 
benzo(k)fluoranthene, benzo(a)pyrene, dibenzo(a,h)anthracene, benzo(ghi)perylene and 
indeno(1,2,3-C,D)pyrene. TraceCERT®, Supelco, Sigma Aldrich (Bellefonte, PA, USA). 
- Deuterated PAH surrogate benzo(e)pyrene-d12 and anthracene-d10, 100 ng/μL in cyclohexane, 
Dr. Ehrenstorfer GmbH (Augsburg, Germany). 
- PAH calibration mix, 2000 µg/mL in methylene chloride containing acenaphthene, 
acenaphthylene, anthracene, benzo(a)anthracene, benzo(a)pyrene, benzo(b)fluoranthene, 
benzo(k)fluoranthene, benzo(ghi)perylene, chrysene, dibenzo(a,h)anthracene, fluoranthene, 
fluorene, indeno(1,2,3-CD)pyrene, naphthalene, phenanthrene and pyrene, Restek Corporation 
(Bellefonte, PA, USA). 
- Deuterated- labelled PAH surrogate cocktail, 200 µg/mL in 50% methylene chloride (D2, 99.9%) 
and 50% methanol (D2, 99%) containing acenaphthylene-d8, benzo(a)pyrene-d12, 
benzo(g,h,i)perylene-d12, fluoranthene-d10, naphthalene-d8, phenanthrene-d10 and pyrene-
d10, Cambridge Isotope Laboratories, Inc. (Andover, MA, USA). 
- Deuterated PAH surrogate benzo(e)pyrene-d12, 100 µg/mL in cyclohexane and chrysene-d12 10 
µg/mL in cyclohexane, Dr. Ehrenstorfer GmbH (Augsburg, Germany). 
- Internal standards: antracene-d10, 10000 µg/mL in cyclohexane and dibenzo(a,h)anthracene-
d14, 10 µg/mL in cyclohexane,  Dr. Ehrenstorfer GmbH (Augsburg, Germany). 
- Disodium salt of the 1,4-piperazinediethanesulfonic acid (PIPES), Sigma Aldrich (USA). 
- Hydrochloric acid 36.5–38%, Baker (Phillipsburg, PA USA). 
- Sodium bicarbonate (NaHCO3), Sigma Aldrich (USA). 
- Sodium hydroxide (NaOH), Sigma Aldrich (USA). 
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- Pepsin from porcine gastric mucosa, Sigma Aldrich (China). 
- Pancreatin from porcine, Sigma Aldrich (USA). 
- Bile salts, Sigma Aldrich (USA). 
- Acetonitrile (ACN), gradient grade for liquid chromatography, Merk (Darmnstadt, Germany). 
- Hexane, n-hexane SupaSolv®, Merk (Darmnstadt, Germany). 
- Methanol (MeOH), gradient quality, Romil (Cambridge, UK). 
 
4.4 Cleaning procedures. 
As we are working with trace analysis, it is essential to maintain the cleanliness during the total 
steps of the analytical procedure (sample collection, transport, storage, preparation and analysis) 
because each of them is a source of sample contamination. In order to do that, all the ware and 
glassware have to be washed with ultrapure water and kept for 48 hours into an alkaline bath owing to 
eliminate the remaining organic components. Finally, it is rinsed many times with ultrapure water again 
before being used. 
 
4.5 Sample collection. 
The sample collection was done using a discontinuous sampler system in order to collect the 
atmospheric particulate matter using a filtration technique, which is the most common sample 
collection. 
The particulate matter collection and characterization by filtration requires two steps: first the 
collection of a representative sample of particulate matter, where the particles are transferred from 
their dispersive state in the air, to a compact one in a filter; and secondly, the analysis of particles by 
using gravimetric, microscopic or other analytical techniques. 
A high-volume sampler, which was the one used in this study, is composed by a size selective 
inlet, which allows us to restrict the diameter of the particles (there are inlets of PM10, PM2.5 and PM1), 
an aspiration system, a sensor to control the flow, in such a way that the variations in the aspiration flux 
are balanced out with the regulation of the flow intensity. There is also a device that controls the 
aspiration time and a filter support.  During its operation, the air goes across the inlets and it is 
accelerated though some nozzles that direct it to an impacting surface where remain detained, 
considering that, in order to avoid the bounce of the particles, the surface is recoat with a layer of 
grease or silicone. At this point, the particles with a larger diameter than the inlet have been retained 
and the ones with a lower size, continue until the filter deposition. 
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In this case, the sample collection was done using the high-volume air sampler Digitel automatic 
high-volume sampler DHA-8 (Figure 4), which is capable of breathing in a range of volumes between 20 
– 100 m3/h. The Digitel automatic high-volume sampler DHA-80 contains, apart from the necessary 
components, a cassette filter loading system for 15 samples and the advantage of having programmable 












Figure 4. External and internal vision of the DHA-8 high-volume sampler. 
The analysis of the particles was performed using gravimetric analysis, where the operation is to 
divide the increase in the filter weight after sampling by the particulate matter volume sampled. The 
mass determination of the particles was done according to the European Legislation, enacted by the Law 
UNE-EN 12341 (1998), being the filters weighted  before and after the sampling. Before each weighting, 
they have to be conditioned at 20 ± 1 °C and at a relative humidity of 45 - 50% for 48 hours. 
Furthermore, it is necessary to consider that all the filters have suffered an exhaustive control during 
their production, have been subdued to 12 hours of calcinations at 400 °C owing to eliminate the 
remaining organic material, and once they were ready to be used, they have been storage individually in 
a freezer at -18 °C. 
The analysed samples come from a high-volume sampler located in the neighbourhood of San 
Diego, in A Coruña. It is an urban area which is highly influenced by traffic emissions and domestic 
activities. In addition, it is next to the sea, being the salt presence very important, more specifically close 
to the port, where hundreds of unloadings occur every day. 
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The analyzed samples are monthly samples of 2015 (excluding May because there were no 
filters due to sampler problems) each of one formed by circular portions of each day of the month, so 
that they are composite samples. The circular portions were obtained using a steel punching tool of 1.6 
cm of diameter, so each sample is formed by thirty portions of 2.01 cm2.  
 
4.6 Bioavailable fraction of PAHs in particulate matter. 
The bioavailable fraction of PAHs was determined with an in-vitro digestion procedure, followed 
by a preconcentration step using a Vortex Asissted Liquid-Liquid Microextraction (VALLME) and a High 
Performance Liquid Chromatography coupled with Fluorescence Detection (HPLC-FD) analysis. 
4.6.1 Extraction of the bioavailable fraction:  in-vitro digestion procedure. 
The current bioavailability studies are based on the in-vitro method for the estimation of 
available iron in food that was done by Miller in 1981 (Miller et al., 1981). The proposed digestion 
procedure was developed by the Analytical Chemistry Department of the A Coruña University and the 
Analytical Chemistry, Nutrition and Bromatology Department of the Santiago de Compostela University 
(Moreda-Piñeiro et al., 2012) (Figure 5). 
 
Figure 5.Flux diagram of the digestion procedure. 
Thirty portions of PM10 corresponding to a month were placed in a 100 mL umber glass flask and 
20 mL of ultra-pure water were added. After fifteen minutes, pH was adjusted at 2 using small volumes 
of hydrochloric acid 6M. Then, a freshly 6.0% gastric solution was prepared just before use with pepsin 
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in a solution of  hydrochloric acid 6 M. Approximately 0.15 g of this solution were added to the flask and 
the simulated gastric digestion took place heating at 37 °C in an incubator coupled to an orbital-
horizontal shaking at 150 rpm during 120 minutes. Once the time has passed, the flasks were placed in 
an ice-water bath to stop the enzymatic digestion. 
While the flask was tempered, the intestinal solution was prepared with 4.0% pancreatin and 
2.5% bile salts dissolved in 0.1M sodium hydrogen carbonate. 5 mL of this solution were added to the 
flasks and the pH was adjusted at 7.5 using NaOH. At that time, a dialysis membrane of 10 KDa 
Molecular Weight Cut-off (MWCO), which is a pore size measure referring to the lowest molecular 
weight of a solute which is retained by the membrane at least in a 90 %, that were previously cleaned 
with ultra-pure water, was introduced in the flask, filled with 20 mL of a PIPES solution 0.15N and a pH 
of 7.53 and closed with plastic tweezers. The flask was placed again in an incubator at 37 °C and shacked 
during 120 minutes at 150 rpm in an orbital-horizontal shaking. At this moment the intestinal digestion 
occurred, and, as a consequence of that, took place the intestinal absorption process simulation using 
the semipermeable dialysis membrane and PIPES as the acceptor solution. 
Finally, while the intestinal digestion had ended, the membrane was removed and the content 
was transferred to a centrifuge vial measuring the exact PIPES volume, because it is there where the 
bioavailable fraction of PAHs was. Blanks were performed followed exactly the same digestion 
procedure in order to control possible contamination. 
 
4.6.2 Preconcentration of the bioavailable fraction. 
The bioavailable fraction of PAHs was analyzed using a High Performance Liquid 
Chromatography (HPLC) system, so it was necessary to have the analytes in a suitable solvent for the 
liquid chromatography injection, an organic one, acetonitrile in this case. 
Once the bioavailable fraction was in the centrifuge vial, the first step was the addition of 
surrogates. A surrogate is a pure compound with a small difference from the analyte which has the same 
chemical properties as the analyte but providing a different analytical signal. They are added in a known 
concentration before an analytical treatment, so they are used to determine the extraction efficiency 
and to correct the experimental errors. In this case, 15 μL of anthracene-d10 50 μgL-1 were added, and 
also 350 μL of hexane. 
The follow step was the Vortex Assisted Liquid-Liquid Microextraction (VALLME). A liquid-phase 
microextraction is a miniaturization of the traditional liquid-liquid extraction, but where the extracting 
solvent is limited to a few microliters for the extraction of the target analytes, causing a 
preconcentration and enhancing the final analysis signal. Here, it was assisted by vortex, which 
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originated an empty center by mechanical energy, influencing positively in the mass transference. This 
technique provides an effective and mild mixing, increasing the contact surface and causing an 
improvement in the extraction recovery. Moreover, the amount of solvent needed is drastically 
reduced, being this technique considered as a green analytical method (Yamini, Rezazadeh and Seidi, 
2019). 
The Vortex was used for 5 minutes, followed by 10 minutes of centrifugation at 3500 rpm. At 
this point, both phases were clearly distinguishable, the lower was the PIPES, and the upper one, the 
350 μL of hexane with the PAHs. The next step was the most complex, removing the organic solvent 
using a glass pipette without taking anything of the aqueous fraction (Figure 6). Finally, the organic 
phase was transferred to an umber vial, 150 μL of ACN were added and the hexane was evaporated with 
a nitrogen flow. The extracts were immediately analyzed in order to avoid the loss of analytes and then, 
storaged in the freezer in case they were necessary to be used again. 
Figure 6. VALLME flux diagram. 
 
4.6.3 Determination of the bioavailable PAHs with HPLC. 
The analytical method for the PAHs determination comes from a previous study of the Analitycal 
Chemistry Department of the A Coruña University. They were analyzed using a Waters 2695 Alliance 
High Performance Liquid Chromatography coupled with fluorescence detection (HPLC-FD).  
High Performance Liquid Chromatography is a separation analytical technique which is based on 
the distribution of the analytes between two different phases, a stationary phase which is a column, and 
a mobile one, a solution that is continuously flowing over the column. This distribution comes from the 
interaction of the analytes in different proportion with these two phases. Reverse phase 
chromatography was used, being the stationary phase less polar than the mobile one. The detection was 
done with a fluorescence detector because they are more sensitive and selective than the UV one. 
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10 μL of the ACN extract were automatically injected in a Waters® PAH C18 (250 X 4.6 mm i.d, 5 
μm) column with a 1 mL min-1 flow rate and a temperature of 32 ± 5°C maintained for all the analysis. A 
gradient elution using acetonitrile and water as mobile phases was performed to achieve the PAHs 
separation, being 50:50 ACN:H2O the initial conditions. The elution program consists of a gradient to 100 
% of ACN in 34 minutes and a return to the initial conditions in 6 minutes, both using linear curves 
(Table 4). The total analysis of a sample required 40 minutes plus 10 extra minutes for the column 
equilibration between runs. Before the chromatographic analysis, the column conditioning was done 
with a system purge using the mobile phase eluents. 
Time (min) % ACN % H2O 
0 50 50 
34 100 0 
40 50 50 
 
Table 4: Choromatographic elution conditions. 
PAHs were monitored using a Waters 2475 fluorescence detector, whose excitation and 
emission wavelengths were selected in order to obtain the highest sensitivity for all the analytes and are 
characterized for each of them (Table 5). 
Time (min) Excitation wavelength (λex) Emission wavelength (λem) 
0 216 330 
11 260 340 
12.9 252 370 
14.6 250 390 
16 284 466 
17.8 272 390 
21 276 406 
26 288 410 
37 300 500 
42 216 330 
 
Table 5. Fluorescence detector events. 
 
4.6.4 Detection and quantification limits. 
The limit of detection (LOD) is defined as the minimum concentration of an analyte which is 
capable of generating an analytical signal that cannot be confused with the blank one at 99% of 
confidence. It is calculated using the Equation 1: 
                                                                𝐿𝑂𝐷 = 3𝑆𝐷 ∙ 𝐷𝐹                                                              𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 1 
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where SD is the standard deviation and DF, the dilution factor. 
The limit of quantification (LOQ) is the minimum concentration of an analyte that generate an 
analytical signal which can be quantified in a trusthworthy way in a confidence level of 99%. It is 
calculated using Equation 2: 
                                                                  𝐿𝑂𝑄 = 10𝑆𝐷 ∙ 𝐷𝐹                                                           𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 2 
where SD is the standard deviation and DF, the dilution factor. 
During this study trace compounds have been analyzed, so the determined concentrations were 
really small, being also the limits, reaching levels of pg/m3 (Table 6). 
Compound LOD (pg/m3) LOQ (pg/m3) 
Naphthalene 0,034 0,11 
Acenaphthene 0,031 0,10 
Fluorene 0,15 0,49 
Phenanthrene 0,062 0,21 
Anthracene 0,16 0,52 
Fluoranthene 0,030 0,10 
Pyrene 0,014 0,048 
benzo(a)anthracene 0,010 0,027 
Chrysene 0,0016 0,0050 
benzo(e)pyrene 0,0056 0,019 
benzo(b+j)fluoranthene 0,045 0,15 
benzo(k)fluoranthene 0,0045 0,015 
benzo(a)pyrene 0,0046 0,15 








Table 6. LOD and LOQ of the analytical method. 
 
4.7 Total concentration of PAHs in particulate matter. 
The total concentration of PAHs in particulate matter was determined using a new green 
analytical method developed by the Analytical Chemistry Department of the A Coruña University with 
the collaboration to the Research Group on Environmental Management and Modeling of the Antioquia 
University (Medellín, Colombia) (Ramos-Contreras et al., 2019). The method was based on a Pressurized 
Hot Water Extraction (PHWE) followed by a miniaturized Membrane-Assisted Solvent Extraction (MASE). 
The concentration determination was done using Programmed Temperature Vaporization-Gas 
Chromatography-Ion Trap tandem Mass spectrometry detection (PTV-GC-MS/MS). 
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4.7.1 Pressurized hot water extraction. 
The pressurized hot water extraction, also called Subcritical Water Extraction (SWE), consists on 
the employ of water submitted to high temperatures, between its boiling point (100 °C, 0.1 MPa) and 
the critical one (374 °C, 22.1 MPa), and enough pressure to keep the water in the liquid state. Under 
these conditions, the physicochemical properties of water change drastically.  
There are some parameters that influence the extraction efficiency, such as solubility, mass 
transfer and the matrix effect; however, there are four which do it in a highest way: temperature, 
pressure, extraction time and flow rate. Among all of them, temperature is crucial. Considering water, 
its dielectric constant decreases with increasing temperature, hence, solvent polarizability can be 
modified with temperature, being lower at higher ones. On the other hand, with the increasing of 
temperature, there are also an increasing in the surface tension and a viscosity degree decreasing, 
increasing the diffusivity. Moreover, high temperatures reduce the intermolecular interactions between 
analytes and matrix, being the mass transfer faster, and, as a consequence of that, improving the 
extraction process (Plaza, 2019). For this reason, it is recognized as a solvent-free technique that is 
considered a green analytical technique. 
This equipment is completely automated, so the operation is very easy, it is only necessary to 
load the sample into the cell, and the equipment itself will control the extraction. Once the sample is 
loaded into the cell, it is filled with the solvent for few minutes, heated and pressurized in the oven. 
These conditions are maintained for a short time and new cleaned solvent is pump into the sample cell, 
originated a new cycle extraction. The number of cycles depends on the analyte and is a parameter that 
has to be optimized. Finally, part of the solvent is purged from the cell with nitrogen flow, and the 
extract is ready for further analysis. 
An accelerated Solvent Extractor Dionex ASE 200 (Figure 7) was used to perform the PAHs 
extraction. Thirty circular portions with a diameter of 0.6 cm and 150 μL of a 200 μg L-1 surrogate 
solution were introduced in 11 mL stainless-steel ASE cells sealed at both ends with two glass-fiber 
filters of diameter 19.8 mm. The surrogate solution is a deuterated PAHs cocktail that contained 
naphthalene d-8, acenaphthylene d-8, phenanthrene d-10, fluoranthene d-10, pyrene d-10, chrysene d-






Figure 7. Illustration of the Acelerated Solvent Extractor Dionex ASE. 
These cells were previously cleaned by extraction with methanol at 150 °C and 2000 psi during 5 
minutes owing to eliminate the interfering compounds that could difficult the analysis. The extraction 
was done using a H2O:MeOH 75:25 (% v/v) solution as extractor solvent,  static time of 5 minutes, 200 °C 
of temperature,  pressure of 2000 psi,  nitrogen purge time of 1 minute and only one extraction cycle 
The PHWE extracts were brought to 40 mL with a H2O:MeOH 3:1 solution and a 15 mL aliquot was 
separated. 
 
4.7.2 Membrane-assisted solvent extraction. 
The Membrane-Assisted Solvent Extraction (MASE) is based on the traditional liquid-liquid 
extraction and is characterized by the analyte diffusion through a membrane from a donor solution to 
another small amount of liquid organic phase, the acceptor solution. The membrane is composed by 
non-porous polypropylene (PP) in order to exclude water traces that could affect following steps. 
The separated 15 mL aliquot was transferred to a 20 mL glass vial to which a high dense PP 
membrane was inserted using a metal funnel with a teflon ring, remaining suspended in the glass vial. 
The membrane was 4 cm long, 0.03 mm thickness and had a diameter of 6 mm. 500 μL of a 100 μg L-1 
internal standard solution of anthracene d-10 and dibenzo(a,h)anthracene d-14 in hexane were added 
and the vial was sealed with a metallic crimp cap with Teflon septa. The MASE device was agitated by 
oscillation at 750 rpm and 30 °C during 90 minutes using a commercial Combi PAL autosampler mounted 
on the Gas Chromatography–Mass Spectrometry system. Once it finished, the hexane extract that 
contained the PAHs has to be analyzed (Figure 8). 
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Figure 8. MASE flow diagram. 
 
4.7.3 Determination of the total PAHs concentration using GC-MS. 
The analytical method for the total PAHs determination in the hexane extract was done using a 
Thermo-Finningan Trace Gas Chromatograph which was equipped with a GC PAL Autosampler, a 
Programmed Temperature Vaporizing injector coupled to an ion trap Mass Spectrometer Polaris Q, 
using Xcalibur as data processor. 
25 μL were injected in a DB-XLB column (60m×0.25mm,0.25µm film thickness), starting the 
injector program at 55°C ad increasing 3°C s-1 until 300°C, temperature that was maintained for 20 
minutes. The oven of the Gas Chromatograph started with a temperature of 50°C during 3 minutes, and 
increased 4°C min-1 to 325°C, hold in 20 minutes. The Mass Spectrometer had an electron impact of 70 
eV, the transfer line temperature was set at 300°C, and the ion source one, at 270°C.Heliumat 99.99% 
was used as collision gas at the ion trap chamber and also as a carrier gas under a constant flow rate of 1 






Product ion       
(m/z) 
Naphtalene 27,12 128 102 
Acenaphthene 38,03 153 150 
Fluorene 41,38 166 162 
Phenanthrene 47,34 178 152 
Anthracene 47,72 178 152 
Fluoranthene 54,85 202 198 
Pyrene 56,28 202 198 
Benz(a)anthracene 63,81 228 224 
Chrysene 64,06 228 224 
Benzo(b+j)fluoranthene 70,23 252 248 
Benzo(k)fluoranthene 70,34 252 248 
Benzo(e)pyrene 71,74 252 248 
Benzo(a)pyrene 72,07 252 248 
Dibenz(a,h)anthracene 78,75 278 274 
Indene(1,2,3-cd)pyrene 78,92 276 272 
Benzo(g,h,i)perylene 80,92 276 272 
 
Table 7. Elution order and conditions of the studied PAHs. 
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4.7.4 Detection and quantification limits. 
The limits of detection (LOD) and limits of quantification (LOQ) of this procedure were calculated 
using Equations 1 and 2. 
Compound LOD (ng/m3) LOQ (ng/m3) 
Naphtalene 0,0026 0,027 
Acenaphthene 0,0011 0,0011 
Fluorene 0,00095 0,00096 
Phenanthrene 0,0041 0,0041 
Anthracene 0,0051 0,0052 
Fluoranthene 0,00086 0,00087 
Pyrene 0,0084 0,00085 
Benz(a)anthracene 0,00037 0,00038 
Chrysene 0,00044 0,00045 
Benzo(e)pyrene 0,00079 0,00080 
Benzo(b+j)fluoranthene 0,0021 0,0022 
Benzo(k)fluoranthene 0,0019 0,0019 
Benzo(a)pyrene 0,0021 0,0021 
Dibenz(a,h)anthracene 0,0065 0,00066 
Benzo(g,h,i)perylene 0,0033 0,0034 
Indene(1,2,3-cd)pyrene 0,0038 0,0039 
 
 Table 8. LOD and LOQ of the analytical method. 
The obtained LOD and LOQ values were low enough to perform the total PAHs determination 
















5. Results and discussion. 
5.1 Bioavailable fraction. 
5.1.2 Quantification of the PAHs bioavailable fraction. 
The PAHs identification was based on their retention times comparing to the internal standard 
solutions (Table 9) of concentrations 0.5, 1, 2, 4, 5, 7 and 10 μg L-1  that were prepared using a PAH 
calibration mix of certified reference material. 
























Table 9. Retention times of the PAHs in the chromatographic analysis. 
Due to the complexity of sample chromatograms, the integration algorithm ApexTrack of the 
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Where 1 is naphthalene, 2 acenapthene, 3 fluorene, 4 phenanthrene, 5 anthracene, 6 fluoranthene, 7 pyrene, , 8 
benzo(a)anthracene, 9 chrysene, 10 benzo(e)pyrene, 11benzo(b+j)fluoranthene, 12 benzo(k)fluoranthene, 13 
benzo(a)pyrene, 14 dibenz(a,h)anthracene, 15 benzo(ghi)perylene and 16 indene(1,2,3-cd)pyrene. 
Figure 9. Chormatogram of a PAHs internal standard solution (blue) and a real sample dialyzate (black). 
The quantification was done taking into account the Relative Response Factor (RRF), which is a 
measure of the analytical response of the technique to an analyte compared to its internal standard. As 
some internal standards were analyzed, the average of the relative response factor of each analyte was 
used to calculate sample concentrations, considering during all the calculations the added surrogates. 
The RRFs were calculated using Equation 3, with a maximum deviation standard coefficient of 4.88% 
(Table 10). Although two different surrogates were added, benzo(e)pyrene-d12 and anthracene-d10, 
and both are acceptable, the calculations were done using the anthracene-d10 values. 
 
RRF =
Areainternal  standard ∙  surrogate vial
 internal standard vial ∙ Areasurrogate
                             Equation 3. 
 
where areainternal standard is the integrated area of the standard PAH in the chromatogram, [surrogate]vial is 
the surrogate concentration in the injected vial, [internal standard]vial is the internal standard 






















Compound RRFs Deviation standard coefficient (%) 
naphthalene 0,19 2,29 
acenaphthene 0,18 2,3 
fluorene 0,41 1,1 
phenanthrene 0,40 1,7 
anthracene 1,1 1,3 
fluoranthene 0,26 2,2 
pyrene 0,57 2,3 
benzo(a)anthracene 1,2 1,0 
chrysene 0,22 0,48 
benzo(e)pyrene 0,22 2,0 
benzo(b+j)fluoranthene 0,30 1,7 
benzo(k)fluoranthene 2,4 1,1 
benzo(a)pyrene 2,1 0,96 








Table 10. Relative response factor of bioavailable PAHs. 
Once the RRFs were obtained, they were used to calculate the bioavailable fraction considering 
the dilutions that were done during the experimental procedure using Equation 4: 
 
                                                 𝑃𝐴𝐻 𝑣𝑖𝑎𝑙  =
𝐴𝑟𝑒𝑎 𝑃𝐴𝐻 ∙  𝑠𝑢𝑟𝑟𝑜𝑔𝑎𝑡𝑒 𝑣𝑖𝑎𝑙
𝐴𝑟𝑒𝑎𝑠𝑢𝑟𝑟𝑜𝑔𝑎𝑡𝑒 ∙ 𝑅𝑅𝐹
 ∙ DF                              Equation 4. 
 
where areaPAH is the integrated area of the PAH in the chromatogram, [surrogate]vial is the surrogate 
concentration in the injected vial, areasurrogate is the integrated area of the surrogate in the 
chromatogram, RRF is the relative response factor and DF, the dilution factor. 
The calculated bioavailable concentrations of each PAH for each month (Table A1) are shown in 
Annex 1. The variation coefficient of the different PAHs concentrations is almost all lower than 20%, 





Figure 10: Monthly graph of the bioavailable PAHs concentration. 
Taking into account the obtained results, first of all it is possible to distinguish the PAHs 
depending on if they generally have a bioavailable fraction or not. There are four that usually are in all 
the samples: phenanthrene, benzo(a)pyrene, chrysene and benzo(e)pyrene; and three that appear 
commonly but with a lower frequency: acenaphthene, pyrene and benzo(k)fluoranthene. On the other 
hand, anthracene, benzo(b)fluoranthene, dibenzo(a,h)anthracene, benzo(ghi)perylene and indene(1,2,3-
cd)pyrene do not have a bioavailable fraction or they have such a smaller one  that cannot be quantified 
with this method. Moreover, naphthalene, fluorene and fluoranthene appear in few samples. 
Focusing on concentrations, phenanthrene has the highest bioavailable concentrations, with 
values of 3,7 pg m-3 in August and 3,6 pg m-3 in April. There are other PAHs that have raised 
concentrations, such as 3,6 pg m-3 of fluoranthene in March, and 3,2 pg m-3 of pyrene in August. 
Nevertheless and fortunately, there are some PAHs whose bioavailable fractions are very small, as in the 
case of benzo(k)fluoranthene, being the PAH with the lowest values, 0,038 and 0,059 pg m-3 in July and 
December for example, and benzo(a)anthracene, with a bioavalable concentration of 0,073 pg m-3. All 
the other compounds are ranged between 0,11 and 2,6 pg m-3.These monthly variation may be due to 
the variation of chemical composition of particulate matter. 
 The atmospheric particulate matter characteristics such as the particle size, the sources of 
origin and their chemical properties have to be also taking into account, because they can react into the 
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with available ligands, redox reactions and dissolutions. Consequently, there are complex synergies and 
antagonisms effects that affect to the major and minor constituents of the atmospheric particulate 
matter and gastrointestinal fluid composition which alter the oral bioavailability of the pollutants 
(Moreda-Piñeiro et al., 2019). 
 
5.1.2 Validation of the analytical method. 
The experimental procedure that has been exposured for the PAHs bioavailable determination is 
a new technique that has been never used. Due to that, it has to be validated in order to prove that the 
method is suitable for the purpose, satisfying the pre-set specifications in relation to its intended use. 
There are some parameters which allow us to carry out this validation, such as the limit of detection, 
limit of quantification, trueness and precision. The first two have just been studied in section 4.6.4, and 
precision, which is the mutual agreement amongst different measurements made in the same sample 
on the same experimental conditions, was considered with standard deviations. 
This section is focused on trueness, which is defined as the degree of agreement between the 
experimental value and the “true value”, having different ways to evaluate it in a laboratory: the use of 
certified reference materials, the application of reference methods published by international 
organizations, interlaboratory exercises and finally, calculating analytical recoveries using standards.  
The trueness of the bioavailable fraction preconcentration was evaluated with analytical 
recoveries. In order to do it, 20 mL of Pipes were fortified with 0.1, 1 and 10 μg L-1 of a PAHs calibration 
mix, and they were treated following exactly  the same procedure as if they were real samples. After the 
concentration determination, the analytical recovery (R) was calculated using Equation 5, obtaining the 
following results (Table 11). 
                                                                 𝑅 % =
 𝑃𝐴𝐻 𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙
 𝑃𝐴𝐻 𝑓𝑜𝑟𝑡𝑖𝑓𝑖𝑒𝑑
∙ 100                                        𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 5. 
where [PAH]experimental is the experimental obtained concentration for the PAH, and [PAH]fortified is the 
theoretical fortified PAH concentration. 
The obtained results should be between 80 - 120 % to be considered correct. In 1 μg L-1 and 10 
μg L-1 fortifications, almost all the values are below 120. However, it is possible to see that in the 0.1 μg 
L-1 fortification, the recoveries are a little bit high because of the concentration is very low. In addition, 
there were problems with fluoranthene and it could be quantified. Nonetheless, the obtained results 




 0,1 μg L-1 fortification 1 μg L-1 fortification 10 μg L-1 fortification 
Naphthalene 109 103 101 
acenaphthene  113 104 105 
Fluorene 121 111 126 
Phenanthrene 143 119 113 
Anthracene 129 119 114 
Fluoranthene - - - 
Pyrene 122 117 120 
benzo(a)anthracene 126 118 123 
Chrysene 140 129 114 
benzo(e)pyrene 106 105 105 
benzo(b+j)fluoranthene 125 119 124 
benzo(k)fluoranthene  122 117 118 
benzo(a)pyrene 128 120 123 
dibenzo(a,h)anthracene 122 118 117 
indene(1,2,3-cd)pyrene 126 119 122 
benzo(ghi)perylene 122 115 116 
 
Table 11. Analytical recoveries using different fortification concentrations. 
 
5.2 Quantification of total PAHs concentration. 
The identification and quantification of PAHs was done following exactly the same procedure as 
for the bioavailable fraction. The identification was established considering the retention time of the 
prepared internal standards using a PAH calibration mix, which had concentrations of 3, 10, 25, 50, 100, 
200 and 300 μg L-1. Moreover, in this technique, the identification was also based on their molecular 
weight owing to the Gas Chromatography was coupled with a Mass Spectroscopy detection. 
For the quantification step, in this case several surrogates were used, and each of them was 
necessary and associated to the quantification of a small group of analytes, which was done using 
Thereupon, the naphthalene d-8 was used for naphthalene, acenaphthylene d-8 for acenaphthene and 
fluorene, phenanthrene d-10 for phenanthrene and anthracene, fluoranthene d-10 for fluoranthene, 
pyrene d-10 for pyrene, chrysene d-12 for chrysene and benzo(a)anthracene, benzo(e)pyrene d-12 for 
benzo(b+j)fluoranthene, benzo(k)fluoranthene, benzo(e)pyrene and benzo(a)pyrene, and finally, 
benzo(ghi)perylene d-12 for dibenzo(a,h)anthracene, indene(1,2,3-cd)pyrene and benzo(ghi)perylene. 
The RRFs were calculated using Equation 5 and all the deviation standard coefficients are between 1.23 
and 10.8%, excepting benzo(a)anthracene, with a value of the 19,5%, still being less than 20%, and 
therefore, correct (Table 12). 
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Compound RRFs Deviation standard coefficient (%) 
naphthalene 0,82 5,1 
acenaphthene 0,26 1,6 
fluorene 0,73 11 
phenanthrene 0,74 5,1 
anthracene 0,56 1,6 
fluoranthene 0,36 1,4 
pyrene 0,42 1,2 
benzo(a)anthracene 1,1 19 
chrysene 1,1 5,2 
benzo(b+j)fluoranthene 1,2 9,9 
benzo(k)fluoranthene  0,63 11 
benzo(e)pyrene 4,4 9,0 
benzo(a)pyrene 0,55 6,6 
dibenzo(a,h)anthracene 0,70 5,90 
indene(1,2,3-cd)pyrene 0,62 8,0 
benzo(ghi)perylene 0,77 5,8 
 
Table 12. Relative response factor of total PAHs. 
The determination of the total concentration of each PAH was done with its corresponding RRF 
and surrogate, using Equation 3. The standard deviation was calculated for each analyte measuring 
three times a known concentration (Table A2), located in Annex 1. The month distribution of each 
PAHs is shown in Figure 11. 
Analyzing the graph, it is clearly distinguished that benzo(e)pyrene and chrysene are the ones 
with the higher presence in the atmosphere, whose concentrations values are ranged from 0,81 ng 
m-3 to 2,91 ng m-3 for the benzo(e)pyrene and 2,13 to 0,61 ng m-3 for the chrysene, being the higher 
value in February and the lower, in June. On the other hand, naphthalene, fluorene and anthracene 
are the least represented, showing concentrations lower than 0,0038 ng m-3 for naphthalene, below 
0,049 ng m-3 for fluorene and underneath 0,084 ng m-3 for anthracene. Benzo(a)pyrene, the only PAH 
whose concentration is regulated in the atmosphere, has values between 0,33 ng m-3 in June and 




Figure 11: Monthly graph of the total PAHs concentration. 
Phenanthrene and acenaphthene have similar values during all the year and all of them are 
lower than 0,35 ng m-3 and 0,11 ng m-3 respectively. The other PAHs, fluoranthene, benzo(a)anthracene, 
pyrene, benzo(b+j)fluoranthene, benzo(k)fluoranthene, dibenzo(a,h)anthracene, indene(1,2,3-cd)pyrene 
and benzo(ghi)perylene have concentration levels that are in the centre of the distribution, with values 
between 0,1 and 1,8 ng m-3. 
 
5.3 Oral bioavailable percentage of PAHs. 
Once the bioavailable and the total concentration of PAHs were determined, the bioavailable 
percentages of each PAH were calculating using Equation 6 (Table 13). 
 
                                   𝐵𝑖𝑜𝑎𝑣𝑎𝑖𝑙𝑎𝑏𝑖𝑙𝑖𝑡𝑦  % =
 𝑏𝑖𝑜𝑎𝑣𝑎𝑖𝑙𝑎𝑏𝑙𝑒 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑃𝐴𝐻
 𝑡𝑜𝑡𝑎𝑙 𝑃𝐴𝐻
∙ 100                       𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 6. 
 
where [bioavailabe fraction]PAH is the concentration of the bioavailable fraction of the PAH, and [total]PAH 
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% Bioavailability January February March April June July 
naphthalene -a -a -a -a 18 -a 
acenaphthene -a 0,34 -a 1,2 -a -a 
fluorene -a -a 1,7 -a -a -a 
phenanthrene 1,8 -a 0,48 1,2 0,26 0,20 
anthracene -a -a -a -a -a -a 
fluoranthene -a -a 0,20 0,32 -a -a 
pyrene -
a -a 0,17 0,20 -a 0,40 
benzo(a)anthracene 0,058 -a 0,062 0,064 0,062 0,029 
chrysene 0,092 0,039 0,079 0,10 0,098 0,060 
benzo(e)pyrene -a 0,048 0,038 -a 0,032 0,030 
benzo(b+j)fluoranthene -a -a -a -a -a -a 
benzo(k)fluoranthene  -a 0,054 0,067 -a -a 0,087 
benzo(a)pyrene -a -a -a -a -a -a 
dibenzo(a,h)anthracene -a -a -a -a -a -a 
indene(1,2,3-cd)pyrene -a -a -a -a -a -a 
benzo(ghi)perylene -a -a -a -a -a -a 
 
 
% Bioavailability August September October November December 
naphthalene -a -a -a 2,3 1,94 
acenaphthene -a -a -a 2,5 5,1 
fluorene -a -a -a 6,8 5,1 
phenanthrene 1,8 -a 0,50 0,33 1,7 
anthracene -a -a -a -a -a 
fluoranthene -a -a -a -a -a 
pyrene 0,87 0,48 0,25 0,43 
 
benzo(a)anthracene -a 0,071 0,051 0,063 0,062 
chrysene -a 0,018 0,075 0,085 0,27 
benzo(e)pyrene -a 0,021 0,024 0,032 0,060 
benzo(b+j)fluoranthene -a -a -a -a -a 
benzo(k)fluoranthene  -a 0,125 -a 0,041 0,066 
benzo(a)pyrene -a -a -a -a -a 
dibenzo(a,h)anthracene -a -a -a -a -a 
indene(1,2,3-cd)pyrene -a -a -a -a -a 
benzo(ghi)perylene -a -a -a -a -a 
-
a
: Not calculated (the PAH concentration in the dialysate or in total concentration is lower than LOQ). 
Table 13. Percentages of the bioavailable fraction of PAHs. 
Due to the obtained results, first of all it is possible to affirm that all the oral bioavailabilites are 
below 7,0 %, excepting naphthalene in June, that has a very high value, 18 %. Naphthalene is the PAH 
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with the highest bioavailability, followed by fluorene, with bioavailabilities of 6,8 % and acenaphthene, 
with values that reach up to 5,0 %. The phenanthrene bioavailability has also considered values that 
ranged between 0,20 and 1,8 %. 
Fluoranthene, pyrene, benzo(a)anthracene, chrysene, benzo(e)pyrene and 
benzo(k)fluoranthene have all of them moderate values between 0,018 and 0,87 %. However, examining 
the results we can affirm that anthracene, benzo(b+j)fluoranthene, benzo(a)pyrene, 
dibenzo(a,h)anthracene and benzo(ghi)perylene have no an oral bioavailability or it is as small as cannot 
be determined with this method. 
Regarding the showed results in Tables 2A and 13 related to the total concentration and the 
bioavailability percentage of PAHs, we can conclude that there is not always a correlation between them 
due to the compounds with higher total concentration were benzo(e)pyrene and chrysene whereas the 
higher bioavailability percentages were from naphthalene and acenaphthene. That is why nowadays it is 













 Oral bioavailability of PAHs, based on an in-vitro approach consisting of using a dialysis 
membrane during the simulated intestinal digestion, was evaluated in different PM10 samples 
collected at urban sites.  
 
 Total PAHs concentration in PM10 samples were in the range of 0,81 ng m
-3 to 2,91 ng m-3 for 
benzo(e)pyrene, the majority PAH, and between 0,0038 and 0,084 ng m-3 for the minority one, 
naphthalene. 
 
 The bioavailable PAHs concentration in PM10 samples are ranged from 0,47 to 3,7 ng m
-3 for 
phenanthrene which is the majority PAH, and from 0,038 and 0,059 pg m-3 for the minority one, 
benzo(k)fluoranthene. 
 
 Low bioavailability percentages (around 7,6 %) have been found for naphthalene in PM10 
samples, whereas fluoranthene, pyrene, benzo(a)anthracene, chrysene, benzo(e)pyrene and 
benzo(k)fluoranthene (bioavailability percentages lower than 0,87 %) are less bioavailable. 
 
 An important difference between concentrations and bioavailable percentages in PM10 samples 
is shown in benzo(a)pyrene, being the one with the higher total concentration and the least 
bioavailable percentage. 
 
 There is an overestimation risk if only the total concentration of a pollutant is evaluated, it is 












 La biodisponibilidad oral de HAPs, basada en una aproximación in-vitro que consiste en el uso de 
una membrana de diálisis durante la simulación de la digestión intestinal, se evaluó en 
diferentes muestras de PM10 procedentes de una zona urbana. 
 
 Las concentraciones totales de muestras de PM10 se encuentran entre 0,81 ng m
-3 y 2,91 ng m-3 
para el benzo(e)pireno que es el HAP mayoritario, y entre 0,0038 y 0,084 ng m-3 para el 
minoritario, el naftaleno. 
 
 Las concentraciones biodisponibles de HAPs en muestras de PM10 se encuentran entre 0,47 y 3,7 
ng m-3 para el fenantreno que es el componente mayoritario, y entre 0,038 y 0,059 pg m-3 para el 
minoritario, el benzo(k)fluoranteno. 
 
 Se determinaron bajos porcentajes de biodisponibilidad (sobre el 7,6 %) para el naftaleno en 
muestras de PM10, mientras que el fluoranteno, pireno, benzo(a)antraceno, criseno, 
benzo(e)pireno y benzo(k)fluoranteno (con porcentajes de biodisponibilidad menores del 0,8 %) 
son menos biodisponibles.  
 
 Existe una importante diferencia entre las concentraciones y los porcentajes de 
biodisponibilidad en muestras de PM10 que aparecen reflejadas en el benzo(e)pireno, siendo el 
HAP con la mayor concentración y el menor porcentaje de biodisponibilidad. 
 
 Tiene lugar una sobrestimación del riesgo si únicamente se tiene en cuenta la concentración 










 A biodispoñibilidade oral de HAPs, basada nunha aproximación in-vitro que consiste no uso 
dunha membrana de diálise durante a simulación da dixestión intestinal, evaluouse en 
diferentes mostras de PM10 procedente dunha zona urbana. 
 
 As concentracións totais de mostras de PM10 atópanse entre 0,81 ng m
-3 e 2,91 ng m-3 para o 
benzo(e)pireno que é o HAP maioritario, e entre 0,0038 e 0,084 ng m-3 para o minoritario, o 
naftaleno. 
 
 As concentracións biodispoñibles de HAPs en mostras de PM10 atópanse entre 0,47 e 3,7 ng m
-3 
para o fenantreno que é o compoñente maioritario, e entre 0,038 e 0,059 pg m-3 para o 
minoritario, o benzo(k)fluoranteno. 
 
 Baixas porcentaxes de biodispoñibilidade (sobre o 7,6 %) foron determinadas para o naftaleno 
en mostras de PM10, mentres que o fluoranteno, pireno, benzo(a)antraceno, criseno, 
benzo(e)pireno e benzo(k)fluoranteno (con porcentaxes de biodispoñibilidade menores do 0,8 
%) son menos biodispoñibles.  
 
 Existe unha importante diferencia entre as concentracións e as porcentaxes de 
biodispoñibilidade en mostras de PM10 que aparecen reflexadas no benzo(e)pireno, sendo  HAP 
coa maior concentración e a menor porcentaxe de biodispoñibilidade. 
 
 Unha sobreestimación do risco ten lugar se únicamente se ten en conta a concentración total do 
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Table 1A: Concentrations of the bioavailable fraction of PAHs. 
 
 


























Ace < 0,10 
 
0,39 15,1 0,48 22 0,17 20 




0,69 3,4 < 0,49 
 
Phe 2,42 1,55 < 0,21 
 
1,0 13 3,6 30 












3,6 6,7 2,4 7,6 




2,1 7,1 1,3 3,9 
BaA 0,25 14,1 < 0,017 
 
0,25 12 0,25 15 
Chry 1,3 0,85 0,83 4,4 1,5 3,7 1,5 13 
BeP < 0,019 
 
1,4 7,8 0,86 7,9 < 0,019 
 








BkF < 0,015 
 
0,14 9,7 0,10 2,2 < 0,015 
 














































































Phe 0,64 9,6 0,47 5,87 3,7 13 < 0,21 
 
















Pyr < 0,048 
 
1,47 3,31 3,2 23 2,5 26 
BaA 0,11 5,6 0,07 7,13 < 0,017 
 
0,27 23 
Chry 0,60 24 0,57 1,14 < 0,0050 
 
0,25 4,5 
BeP 0,26 10 0,41 12 < 0,019 
 
0,42 7,5 








BkF < 0,015 
 
0,039 15 < 0,015 
 
0,11 20 








DBahA < 0,015  < 0,015  < 0,015  < 0,015  
BghiP < 0,020  < 0,020  < 0,020  < 0,020  









 October November December 









 (pg m-3) 
Variation coefficient 
(%) 
Nap < 0,11  0,36 19 0,57 9,9 
Ace < 0,10  0,63 9,7 0,97 11 
Fl 1,03 19 2,2 2,9 1,85 10 
Phe 0,78 32 0,71 13 3,39 30 
Ant < 0,52  < 0,52  < 0,52  
Ft < 0,10  < 0,10  < 0,10  
Pyr 1,16 12 2,89 15 < 0,048  
BaA 0,14 2,8 0,31 9,7 0,27 6,2 
Chry 0,72 23 1,1 24 2,6 12 
BeP 0,35 29 0,59 0,91 0,71 10 
BbF < 0,15  < 0,15  < 0,15  
BkF < 0,015  0,078 19 0,060 10 
BaP < 0,15  < 0,15  < 0,15  
DBahA < 0,015  < 0,015  < 0,015  
BghiP < 0,020  < 0,020  < 0,020  







Table A2.Total concentrations of PAHs. 
 
 
Concentration (ng m-3) January February March April June July 
naphthalene 0,084 0,0038 < 0,027 < 0,027 0,0046 0,0058 
acenaphthene 0,061 0,11 < 0,0011 0,014 0,030 0,028 
fluorene < 0,00096 0,049 0,040 0,017 0,014 0,018 
phenanthrene 0,13 0,35 0,22 0,31 0,24 0,23 
anthracene 0,0080 0,084 0,013 0,022 0,10 0,031 
fluoranthene 0,47 1,2 1,8 0,76 0,30 0,46 
pyrene 0,47 1,1 1,2 0,64 0,25 0,36 
benzo(a)anthracene 0,43 0,73 0,40 0,39 0,18 0,26 
chrysene 1,4 2,1 1,9 1,5 0,61 0,96 
benzo(b+j)fluoranthene 2,2 2,9 2,3 2,0 0,81 1,3 
benzo(k)fluoranthene 2,2 1,3 0,96 0,76 0,42 0,56 
benzo(e)pyrene 0,62 0,27 0,15 0,12 < 0,00080 0,044 
benzo(a)pyrene 0,69 0,96 0,70 0,71 0,33 0,51 
dibenzo(a,h)anthracene 0,13 0,27 0,078 0,21 0,41 0,21 
indene(1,2,3-cd)pyrene 1,2 1,0 0,85 0,49 0,55 0,61 








Concentration (ng m-3) August September October November December 
Standard 
deviation  
naphthalene < 0,027 < 0,027 < 0,027 0,016 0,030 7,8 
acenaphthene  0,030 < 0,0011 < 0,0011 0,025 0,020 5,8 
fluorene 0,032 < 0,00096 < 0,00096 0,032 0,037 11 
phenanthrene 0,21 0,15 0,15 0,22 0,20 7,1 
anthracene 0,026 0,075 0,012 0,0083 0,024 11 
fluoranthene  0,072 < 0,00087 0,48 0,27 2,5 
pyrene 0,37 0,53 0,46 0,67 0,54 3,1 
benzo(a)anthracene 0,21 0,39 0,28 0,50 0,45 14 
chrysene 0,98 1,4 0,95 1,3 0,95 13 
benzo(b+j)fluoranthene 1,3 2,0 1,5 1,88 1,2 3,4 
benzo(k)fluoranthene  0,47 0,75 0,59 0,75 0,60 6,0 
benzo(e)pyrene 0,034 0,084 0,019 0,19 0,090 4,1 
benzo(a)pyrene 0,39 0,56 0,44 0,84 0,78 5,3 
dibenzo(a,h)anthracene 0,18 0,086 < 0,00066 0,073 0,050 10 
indene(1,2,3-cd)pyrene 0,53 0,21 0,039 0,61 0,67 4,4 
benzo(ghi)perylene 0,70 0,88 0,78 0,86 0,84 7 
 
 
 
